Close

Karyopharm Therapeutics (KPTI) to Update on Multiple Myeloma Trajectory; Plans Expansion of Selinexor Phase 2b

Go back to Karyopharm Therapeutics (KPTI) to Update on Multiple Myeloma Trajectory; Plans Expansion of Selinexor Phase 2b